Seven of 368 cases of acute myeloid leukemia (AML) could not be subclassified by routine morphologic, cytochemical and immunologic analyses during the period January 1989 to December 1990. Further investigations including ultrastructural examination, anti-myeloperoxidase and myeloid specific antigen analysis were carried out in all these patients and they were classified as AML-MO, as per the FAB criteria. Morphologically these blasts resembled ALL-L2/AML-M1. Cytochemlcally they were negative for Sudan black, myeloperoxidase, periodic acid-Schiff, and non-specific esterase. On initial immunophenotypic analysis, they could not be classified Into B, T or myeloid lineages. Further investigations revealed CD13 and CD33 positivity in 4 of 6 patients. Anti-myeloperoxidase was positive in 6 of 6 patients and ultrastructural examination revealed myeloperoxidase-positive blasts in 6 of 7 cases. Cytogenetic analysis done in one patient revealed 60 % abnormal metaphases. Six of 7 cases were treated with aggressive chemotherapy. One patient achieved complete remission but relapsed after 6 months, whereas others were resistant to treatment. Hence we conclude that an aggressive investigative and therapeutic approach is required to identify and treat AML-MO.
Get full access to this article
View all access options for this article.
References
1.
AndersonW.A., TrantalisJ., KangJ.H.: Ultrastructural localisation of endogenous mammary gland peroxidase during lactogenesis in the rat: results after tannic acid-formaldehyde-degluteraldehyde fixation. J. Histochem. Cytochem., 23: 295–302, 1975.
2.
BennettJ.M., CatovskyD., DanielM.T., FlandrinG., GaltonD.A.G.: Criteria for diagnosis of acute leukemia of megakaryocytic lineage (M7). Ann. Inter. Med., 103, 460–462, 1985.
3.
BennettJ.M., CatovskyD., DanielM.-T., FlandrinG., GaltonD.A.G., GralnickH.R., SultanC.: Proposed revised criteria for the classification of acute myeloid leukemia. Ann. Intern. Med., 103: 620–625, 1985.
4.
BennettJ.M., CatovskyD., DanielM.-T., FlandrinG., GaltonD.A.G., GralnickH.R., SultanC.: Proposal for the recognition of minimally differentiated acute myeloid leukemia (AML-MO). Br. J. Hematol., 78: 325–329, 1991.
5.
Breton-GoriusJ., ReyesF., DuhanelG., NajmanA., GorinN.C.: Megakaryocytic acute leukemia: identification by the ultrastructural demonstration of platelet peroxidase. Blood, 51: 45–48, 1978.
CatovskyD., MatutesE., BuccheriV., ShettyV., HanslipJ., YoshidaN., MorillaR.: A classification of acute leukemia for the 1990s. Ann. Hematol., 62: 16–21, 1991.
9.
ChesonB.D., CassilethP.A., HeadD.R., SchifferC.A., BennettJ.M., BloomfieldC.D., BrunningR., GaleR.P., GreverM.R., KeatingM.J., SawitskyA., StassS., WeinsteinH., WoodsW.G.: Report of the National Cancer Institute Sponsored Workshop on Definitions of Diagnosis and Response in acute myeloid leukemia. J. Clin. Oncol., 8: 813–819, 1990.
10.
FerrariS., TagliaficoE., TemperaniP., ManfrediniR., CeccherelliG., ZucchiniP., TabilioA., DonelliA., TorelliG., EmeliaG., TorelliU.: Overexpression of the MPO-gene occurring in a case of acute promyelocytic leukemia without the unusual genotypic characteristics. Leukemia Res., 14: 735–742, 1990.
11.
GrahamR.C., KarnovskyM.J.: Early stage observation of injected horse raddish peroxide in the proximal tubules of mouse kidney: ultrastructural cytochemistry by a new technique. J. Histochem. Cytochem., 14: 291–302, 1966.
MarieJ.P., PerrotJ.Y., BoucheixC., ZittounJ., MartyreM.C., KayibandaM., RosenfeldC., MishalZ., ZittounR.: Determination of ultrastructural peroxidases and immunological markers in the diagnosis of acute leukemias. Blood, 59: 270–276, 1982.
15.
MertelsmannR., ThalerH.T., ToL., GeeT.S., McKenzieS., SchauerP., FriedmanA., ArlinZ., ClirrinicioneC., ClarksonB.: Morphological classification, response to therapy and survival in 263 adult patients with acute non-lymphocytic leukemia. Blood, 56: 773–779, 1980.
16.
NairC.N., GothoskarB.P., GladstoneB.: Terminal deoxyribonucleotide transferase in acute leukemias by direct fluorescence. Neoplasma, 34: 305–311, 1987.
17.
ParrieraA., Pombo de OliveiraM.S., MatutesE., ForoniL., MorrilaR., CatovskyD.: Terminal deoxynucleotidyl trans-rase positive acute myeloid leukemia: an association with immature myeloblastic leukemia. Br. J. Hematol, 69: 219–224, 1988.
18.
PolliN., O'BrienM., Tavares de CastroJ., MatutesE., San-MiguelJ.F., CatovskyD.: Characterisation of blast cells in chronic granulocytic leukemia in transformation, acute myelofibrosis and undifferentiated leukemia. Br. J. Hematol., 59: 277–296, 1985.
19.
Pombo de OliveiraM.S., MatutesE., RaniS., MorillaR., CatovskyD.: Early expression of MCS2 (CD13) in the cytoplasm of blast cells from acute myeloid leukemia. Acta Hematol., 80: 61–64, 1988.
Van der SchootC.E., DaamsolG.M., PurksterJ., VetR., Von dem BorneA.E.G.K.: Monoclonal antibodies against myeloperoxidase are valuable immunological agents for diagnosis of acute myeloid leukemia. Br. J. Hematol., 74: 173–178, 1990.
22.
YounessE., TrujilloJ.M., AhearsM.J., McCredieK.B., CorkA.: Acute unclassified leukemia. A clinicopathologic study with diagnostic implications of electron microscopy. Am. J. Hematol., 9: 79–92, 1990.
23.
ZakiS.R., AustinG.E., SwanD., SrinivasanA., RagabA.H., ChanW.C.: Human myeloperoxidase gene expression in acute leukemias. Blood, 74: 2096–2102, 1989.
